We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of a FLAER-Based WBC Assay in the Primary Screening of PNH Clones.
- Authors
D. Robert Sutherland
- Abstract
Diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) with flow cytometry traditionally involves the analysis of CD55 and CD59 on RBCs and neutrophils. However, the ability to accurately detect PNH RBCs is compromised by prior hemolysis and/or transfused RBCs. Patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS) can also produce PNH clones. We recently described a multiparameter fluorescent aerolysin (FLAER)-based flow assay using CD45, CD33, and CD14 that accurately identified PNH monocyte and neutrophil clones in PNH, AA, and MDS. Here, we compared the efficiency of this WBC assay with a CD59-based assay on RBCs during a 3-year period. PNH clones were detected with the FLAER assay in 63 (11.8%) of 536 samples tested, whereas PNH RBCs were detected in only 33 (6.2%), and always with a smaller clone size. The FLAER assay on WBCs is a more sensitive and robust primary screening assay for detecting PNH clones in clinical samples.
- Subjects
PAROXYSMAL hemoglobinuria; DIAGNOSTIC use of flow cytometry; LEUCOCYTES; NEUTROPHILS; HEMOLYSIS &; hemolysins; APLASTIC anemia; CLONING; PATIENTS
- Publication
American Journal of Clinical Pathology, 2009, Vol 132, Issue 4, p564
- ISSN
0002-9173
- Publication type
Article
- DOI
10.1309/AJCPMRDZZFQM7YJ4